Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck CancerEben L. Rosenthal, Kurt R. Zinn, Anthony B. Morlandt et al.|Clinical Cancer Research|2015Cited by 477
Oncologic Procedures Amenable to Fluorescence-guided SurgeryKiranya E. Tipirneni, Eben L. Rosenthal, Jason M. Warram et al.|Annals of Surgery|2016Cited by 155
Sensitivity and Specificity of Cetuximab-IRDye800CW to Identify Regional Metastatic Disease in Head and Neck CancerEben L. Rosenthal, Jason M. Warram, Lindsay S. Moore et al.|Clinical Cancer Research|2017Cited by 152
WPOI-5: Accurately Identified at Intraoperative Consultation and Predictive of Occult Cervical MetastasesJohn E. Beute, Mark L. Urken, Lily Greenberg et al.|Head and Neck Pathology|2023Cited by 9